CHAN MEDI-PHARM is an ecumenical drug supply organization founded by three prominent church bodies to coordinate the provision of essential medicines and medical consumables for church owned health facilities in the country.
It is a subsidiary and the drug supply and distribution arm of the Christian Health Association of Nigeria (CHAN), which has been in operations since 1979. The founding bodies include:
- The Catholic Bishop’s Conference of Nigeria
- The Christian Council of Nigeria
- The Northern Christian Medical Advisory Council
CHAN has a membership strength of over 400 Member Institutions (MIs) otherwise called mission hospitals and anther 4000 primary healthcare facilities affiliated to the mission hospitals.
The Member Institutions render a wide scope of healthcare services from Primary to Tertiary and spread across various locations providing healthcare services in Nigeria with the overall mission of reaching the “unreached”, and making available, affordable and equitable healthcare to the economically and geographically disadvantaged populations in the country.
CORE COMPETENCIES
CHAN Medi-Pharm has over 30 years experience in the business of bulk/pooled procurement, warehousing and distribution of essential medicines and medical consumables. Our core values include:
| |
 |
|
Drug and Commodity Supply Management Services: |
| |
|
|
Port and Customs Clearance |
| |
|
|
Drug Management & Information Systems |
| |
|
|
Training and capacity building |
| |
|
|
System design and development in such areas as: |
| |
|
|
rational use and sustainable drug revolving fund scheme with mechanisms to provide for the indigent and medically needy |
| |
|
|
Formulary management |
OBJECTIVES
Over the years, the main thrust of operation of CHAN MEDI-PHARM has been hooked on achieving the following objectives:
| |
|
|
Promotion of equity of access to essential medicines by the poor and medically needy through a network of rural-based healthcare system and drug depots |
| |
|
|
Promotion of use of generic essential medicines enabling a reduction in costs of treatment for the poor |
| |
|
|
Promotion of access to antiretroviral medicines through the use of generic ARVs |
| |
|
|
Promotion of rational use of medicines in order that patients may get greater value for their patronage as well as reduction of untoward effects of medicines on consumers. |
|
